Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Other Non-Current Assets (2016 - 2025)

Dexcom (DXCM) has disclosed Other Non-Current Assets for 16 consecutive years, with $278.7 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 61.1% to $278.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $278.7 million through Dec 2025, up 61.1% year-over-year, with the annual reading at $278.7 million for FY2025, 61.1% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $278.7 million at Dexcom, up from $276.5 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $278.7 million in Q4 2025, with the low at $10.5 million in Q4 2021.
  • Average Other Non-Current Assets over 5 years is $93.5 million, with a median of $74.4 million recorded in 2023.
  • The sharpest move saw Other Non-Current Assets plummeted 50.93% in 2021, then skyrocketed 348.57% in 2022.
  • Over 5 years, Other Non-Current Assets stood at $10.5 million in 2021, then surged by 348.57% to $47.1 million in 2022, then surged by 59.24% to $75.0 million in 2023, then skyrocketed by 130.67% to $173.0 million in 2024, then soared by 61.1% to $278.7 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $278.7 million, $276.5 million, and $175.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.